Glucosamine Alzheimer's Risk & McDonald's GLP-1 Menu Bet

Podcast: The Health Marketing Daily · Marco & Klara

Opublikowano: 2026-09-28

McDonald's just named GLP-1 users a core menu audience with an $8B commitment — and glucosamine, one of Europe's top joint supplements, is now linked to faster Alzheimer's progression. Both stories demand action from supplement and functional food marketers today. In this episode: A large health-record analysis found glucosamine users face a 25% higher likelihood of progressing from mild cognitive impairment to full dementia, putting serious reputational pressure on one of Europe's best-selling joint supplements. McDonald's has announced an $8B-plus strategic investment that explicitly redesigns its menu for GLP-1 drug users seeking smaller portions and higher protein density — the...